Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 24, Number 5—May 2018

Human Usutu Virus Infection with Atypical Neurologic Presentation, Montpellier, France, 2016

Yannick SimoninComments to Author , Olivier Sillam, Marie J. Carles, Serafin Gutierrez, Patricia Gil, Orianne Constant, Marie F. Martin, Gilda Grard, Philippe Van de Perre, Sara Salinas, Isabelle Leparc-Goffart, and Vincent Foulongne
Author affiliations: Université de Montpellier, Montpellier, France (Y. Simonin, O. Constant, M.F. Martin, P. Van de Perre, S. Salinas, V. Foulongne); Université de Montpellier Hôpital, Montpellier (O. Sillam); Nimes University Hospital, Nimes, France (M.J. Carles); Centre de Coopération Internationale en Recherche Agronomique pour le Développement, Montpellier (S. Gutierrez, P. Gil); Institut de Recherche Biomédicale des Armées, Marseille, France (G. Grard, I. Leparc-Goffart)

Main Article


Clinical conditions or symptoms associated with microbial investigations of cerebrospinal fluid samples for infections with arboviruses, France*

Condition No. (%) positive samples
Meningitis/encephalitis 277 (41.6)
Neurologic disorders† 233 (34.9)
Febrile syndrome 108 (16.2)
Other 48 (7.0)
Total 666 (100.0)

*Samples collected at the Université de Montpellier Hôpital (Montpellier, France) and Nîmes University Hospital (Nimes, France) during May–November 2016.
†Including (if >2%) convulsion/epileptic seizure (25%); paralysis/paresthesia/polyradiculoneuritis/motor loss/palsy (31%); myelitis (2%); vascularitis (3%); encephalopathy (6%); Guillain-Barré syndrome (4%), headache (15%); and confusion (10%).

Main Article

Page created: April 24, 2018
Page updated: April 24, 2018
Page reviewed: April 24, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.